Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech)
Thomas Nicol, Caroline Lefeuvre, Orianne Serri, Adeline Pivert, Françoise Joubaud, et al.. Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech). Journal of Clinical Virology, Elsevier, 2020, 129, pp.104511. ⟨10.1016/j.jcv.2020.104511⟩. ⟨hal-03443223⟩